Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1125 of 1294 entries
View as:

Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00474045 Org: User:
Start: 05/31/07 End: 08/31/10 Due: 08/31/11

A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05069545 Org: User:
Start: 10/11/21 End: 09/10/24 Due: 09/10/25

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Phase: N/A Priority: Normal
NCT ID: NCT01511393 Org: User:
Start: 01/31/12 End: 12/31/39 Due: 12/31/40

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02730377 Org: User:
Start: 03/28/16 End: 08/12/19 Due: 08/12/20

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Phase: N/A Priority: Normal
NCT ID: NCT05669755 Org: User:
Start: 03/01/23 End: 10/13/27 Due: 10/13/28

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT04822181 Org: User:
Start: 04/01/21 End: 04/25/29 Due: 04/25/30

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01952145 Org: User:
Start: 09/20/13 End: 11/04/14 Due: 11/04/15

A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05624580 Org: User:
Start: 11/15/22 End: 10/25/25 Due: 10/25/26

Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01517555 Org: User:
Start: 10/31/06 End: 05/31/07 Due: 05/31/08

A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04560998 Org: User:
Start: 10/01/20 End: 07/12/24 Due: 07/12/25

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before

Phase: N/A Priority: Normal
NCT ID: NCT04460885 Org: User:
Start: 11/25/20 End: 12/01/22 Due: 12/01/23

A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

Phase: N/A Priority: Normal
NCT ID: NCT04848480 Org: User:
Start: 04/30/21 End: 12/02/22 Due: 12/02/23

Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04982575 Org: User:
Start: 08/02/21 End: 07/07/22 Due: 07/07/23

A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT04597697 Org: User:
Start: 12/22/20 End: 03/24/22 Due: 03/24/23

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06797869 Org: User:
Start: 01/29/25 End: 08/21/26 Due: 08/21/27

Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01508923 Org: User:
Start: 05/31/01 End: 02/28/02 Due: 02/28/03

An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT01689025 Org: User:
Start: 09/30/12 End: 02/28/14 Due: 02/28/15

A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01469143 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01934712 Org: User:
Start: 08/30/13 End: 01/28/14 Due: 01/28/15

First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01611688 Org: User:
Start: 06/04/12 End: 06/17/13 Due: 06/17/14

Use of NovoSeven® in Active Variceal Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00154492 Org: User:
Start: 04/30/04 End: 08/31/06 Due: 08/31/07

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Phase: N/A Priority: Normal
NCT ID: NCT00710619 Org: User:
Start: 06/30/08 End: 07/31/09 Due: 07/31/10

Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06517784 Org: User:
Start: 07/05/24 End: 08/16/24 Due: 08/16/25

Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01520831 Org: User:
Start: 04/30/99 End: 05/31/00 Due: 05/31/01

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

Phase: N/A Priority: Normal
NCT ID: NCT00853086 Org: User:
Start: 01/31/08 End: 06/30/11 Due: 06/30/12